These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2552183)

  • 21. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical studies on recurrence of urolithiasis. (2) Hypercalciuria and recurrence of urolithiasis].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Nov; 33(11):1766-71. PubMed ID: 3445858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eventual attenuation of hypocalciuric response to hydrochlorothiazide in absorptive hypercalciuria.
    Preminger GM; Pak CY
    J Urol; 1987 Jun; 137(6):1104-9. PubMed ID: 3586136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoters and inhibitors of calcium urolithiasis in children.
    Lama G; Carbone MG; Marrone N; Russo P; Spagnuolo G
    Child Nephrol Urol; 1990; 10(2):81-4. PubMed ID: 2253256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the urinary stone former.
    Drach GW
    Semin Urol; 1984 Feb; 2(1):12-9. PubMed ID: 6463458
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood amino acids and aminoaciduria in urinary calculosis].
    Borgno M; Frea B; Perolino PM; Tizzani A
    Minerva Urol; 1974; 26(5):195-202. PubMed ID: 4449538
    [No Abstract]   [Full Text] [Related]  

  • 27. The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?
    Robertson WG; Peacock M
    Nephron; 1980; 26(3):105-10. PubMed ID: 7412965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterozygous cystinuria and calcium oxalate urolithiasis.
    Carpentier PJ; Kurth KH; Blom W; Huijmans JG
    J Urol; 1983 Aug; 130(2):302-4. PubMed ID: 6876277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resorptive and absorptive hypercalciuria. Therapy with sodium cellulose phosphate or thiazides.
    Hering F; Lutzeyer W
    Eur Urol; 1979; 5(1):29-31. PubMed ID: 428408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E
    Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic evaluation in stone patients in relation to extracorporeal shock wave lithotripsy treatment.
    Lycklama à Nijeholt GA; Tan HK; Papapoulos SE
    J Urol; 1991 Dec; 146(6):1478-81. PubMed ID: 1942322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proceedings: Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease and relationship to urolithiasis.
    Farmer RG; Mir-Madjlessi SH; Kiser WS
    Gut; 1973 Oct; 14(10):828. PubMed ID: 4758698
    [No Abstract]   [Full Text] [Related]  

  • 34. Osteocalcin response to calcium-restricted diet: a helpful tool for the workup of hypercalciuria.
    Strohmaier WL; Schlee-Giehl K; Bichler KH
    Eur Urol; 1996; 30(1):103-7. PubMed ID: 8854076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for biochemical abnormalities in urolithiasis patients.
    Orakzai N; Hanbury DC; Farrington K
    J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of mucopolysaccharide elimination in urolithiasis].
    Hesse A; Hartmann U; Schneider HJ; Horn G
    Z Urol Nephrol; 1975 Jun; 70(6):401-5. PubMed ID: 127480
    [No Abstract]   [Full Text] [Related]  

  • 37. Calcium metabolism in normal and in hypercalciuric patients on Farnolith, a dietary fibre preparation.
    Strohmaier WL; Kalchthaler M; Bichler KH
    Urol Res; 1988; 16(6):437-40. PubMed ID: 2852867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic evaluation of urolithiasis.
    Hwang TI; Yang CR; Chang CL; Chang CH; Wu HC
    J Formos Med Assoc; 1990 Jul; 89(7):577-81. PubMed ID: 1979600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are stone formers maladapted to refined carbohydrates?
    Rao PN; Gordon C; Davies D; Blacklock NJ
    Br J Urol; 1982 Dec; 54(6):575-7. PubMed ID: 6758911
    [No Abstract]   [Full Text] [Related]  

  • 40. Graphic display of urinary risk factors for renal stone formation.
    Pak CY; Skurla C; Harvey J
    J Urol; 1985 Nov; 134(5):867-70. PubMed ID: 4057368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.